AKTX
Akari Therapeutics
AKTX
AKTX
15 hedge funds and large institutions have $4.19M invested in Akari Therapeutics in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.24%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
3
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Millennium Management
New York
|
$27K |
2 |
2
Citadel Advisors
Miami,
Florida
|
$7.57K |
3 |
3
Renaissance Technologies
New York
|
$26K |
4 |
TSS
4
Two Sigma Securities
New York
|
$6.31K |
5 |
5
LPL Financial
San Diego,
California
|
$63.2K |
Top Sellers
1 |
AC
1
Armistice Capital
New York
|
$1.63M |
2 |
SM
2
Sabby Management
Miami Beach,
Florida
|
$1.72M |
3 |
HTC
3
Haverford Trust Company
Radnor,
Pennsylvania
|
$0 |
4 |
TC
4
Truvestments Capital
Sarasota,
Florida
|
$472 |